United States Cardiac Biomarkers Market Report 2017

Name: United States Cardiac Biomarkers Market Report 2017
Brand: QYResearch
SKU: UBBB37926B3EN
Price: 3800 USD
Availability: InStock

November 2017 | 95 pages | ID: UBBB37926B3EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Cardiac Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Cardiac Biomarkers in these regions, from 2012 to 2022 (forecast).

United States Cardiac Biomarkers market competition by top manufacturers/players, with Cardiac Biomarkers sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Abbott Laboratories
Alere
Siemens Healthcare GmbH
Roche Diagnostics Corporation
Beckman Coulter, Inc.
BG Medicines
Thermo Fisher Scientific, Inc.
BioMerieux SA
Bio-Rad Laboratories

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Troponin
LDH isoenzymes
Myoglobin
Ischemia Modified Albumin (IMA)
Heart-type Fatty Acid Binding Protein (H-FABP)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Cardiomyopathy
Ischemia
Myocarditis
Atrial Fibrillation

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Cardiac Biomarkers Market Report 2017

1 CARDIAC BIOMARKERS OVERVIEW

1.1 Product Overview and Scope of Cardiac Biomarkers
1.2 Classification of Cardiac Biomarkers by Product Category
  1.2.1 United States Cardiac Biomarkers Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Cardiac Biomarkers Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Troponin
  1.2.4 LDH isoenzymes
  1.2.5 Myoglobin
  1.2.6 Ischemia Modified Albumin (IMA)
  1.2.7 Heart-type Fatty Acid Binding Protein (H-FABP)
1.3 United States Cardiac Biomarkers Market by Application/End Users
  1.3.1 United States Cardiac Biomarkers Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Acute Coronary Syndrome
  1.3.3 Myocardial Infarction
  1.3.4 Congestive Heart Failure
  1.3.5 Cardiomyopathy
  1.3.6 Ischemia
  1.3.7 Myocarditis
  1.3.8 Atrial Fibrillation
1.4 United States Cardiac Biomarkers Market by Region
  1.4.1 United States Cardiac Biomarkers Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Cardiac Biomarkers Status and Prospect (2012-2022)
  1.4.3 Southwest Cardiac Biomarkers Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Cardiac Biomarkers Status and Prospect (2012-2022)
  1.4.5 New England Cardiac Biomarkers Status and Prospect (2012-2022)
  1.4.6 The South Cardiac Biomarkers Status and Prospect (2012-2022)
  1.4.7 The Midwest Cardiac Biomarkers Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cardiac Biomarkers (2012-2022)
  1.5.1 United States Cardiac Biomarkers Sales and Growth Rate (2012-2022)
  1.5.2 United States Cardiac Biomarkers Revenue and Growth Rate (2012-2022)

2 UNITED STATES CARDIAC BIOMARKERS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Cardiac Biomarkers Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cardiac Biomarkers Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cardiac Biomarkers Average Price by Players/Suppliers (2012-2017)
2.4 United States Cardiac Biomarkers Market Competitive Situation and Trends
  2.4.1 United States Cardiac Biomarkers Market Concentration Rate
  2.4.2 United States Cardiac Biomarkers Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cardiac Biomarkers Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CARDIAC BIOMARKERS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Cardiac Biomarkers Sales and Market Share by Region (2012-2017)
3.2 United States Cardiac Biomarkers Revenue and Market Share by Region (2012-2017)
3.3 United States Cardiac Biomarkers Price by Region (2012-2017)

4 UNITED STATES CARDIAC BIOMARKERS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Cardiac Biomarkers Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cardiac Biomarkers Revenue and Market Share by Type (2012-2017)
4.3 United States Cardiac Biomarkers Price by Type (2012-2017)
4.4 United States Cardiac Biomarkers Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CARDIAC BIOMARKERS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Cardiac Biomarkers Sales and Market Share by Application (2012-2017)
5.2 United States Cardiac Biomarkers Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CARDIAC BIOMARKERS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Abbott Laboratories
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cardiac Biomarkers Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abbott Laboratories Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Alere
  6.2.2 Cardiac Biomarkers Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Alere Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Siemens Healthcare GmbH
  6.3.2 Cardiac Biomarkers Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Siemens Healthcare GmbH Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Roche Diagnostics Corporation
  6.4.2 Cardiac Biomarkers Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Roche Diagnostics Corporation Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Beckman Coulter, Inc.
  6.5.2 Cardiac Biomarkers Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Beckman Coulter, Inc. Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 BG Medicines
  6.6.2 Cardiac Biomarkers Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 BG Medicines Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Thermo Fisher Scientific, Inc.
  6.7.2 Cardiac Biomarkers Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 BioMerieux SA
  6.8.2 Cardiac Biomarkers Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 BioMerieux SA Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bio-Rad Laboratories
  6.9.2 Cardiac Biomarkers Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bio-Rad Laboratories Cardiac Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 CARDIAC BIOMARKERS MANUFACTURING COST ANALYSIS

7.1 Cardiac Biomarkers Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cardiac Biomarkers

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cardiac Biomarkers Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cardiac Biomarkers Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CARDIAC BIOMARKERS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Cardiac Biomarkers Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cardiac Biomarkers Sales Volume Forecast by Type (2017-2022)
11.3 United States Cardiac Biomarkers Sales Volume Forecast by Application (2017-2022)
11.4 United States Cardiac Biomarkers Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Cardiac Biomarkers
Figure United States Cardiac Biomarkers Market Size (K Units) by Type (2012-2022)
Figure United States Cardiac Biomarkers Sales Volume Market Share by Type (Product Category) in 2016
Figure Troponin Product Picture
Figure LDH isoenzymes Product Picture
Figure Myoglobin Product Picture
Figure Ischemia Modified Albumin (IMA) Product Picture
Figure Heart-type Fatty Acid Binding Protein (H-FABP) Product Picture
Figure United States Cardiac Biomarkers Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Cardiac Biomarkers by Application in 2016
Figure Acute Coronary Syndrome Examples
Table Key Downstream Customer in Acute Coronary Syndrome
Figure Myocardial Infarction Examples
Table Key Downstream Customer in Myocardial Infarction
Figure Congestive Heart Failure Examples
Table Key Downstream Customer in Congestive Heart Failure
Figure Cardiomyopathy Examples
Table Key Downstream Customer in Cardiomyopathy
Figure Ischemia Examples
Table Key Downstream Customer in Ischemia
Figure Myocarditis Examples
Table Key Downstream Customer in Myocarditis
Figure Atrial Fibrillation Examples
Table Key Downstream Customer in Atrial Fibrillation
Figure United States Cardiac Biomarkers Market Size (Million USD) by Region (2012-2022)
Figure The West Cardiac Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cardiac Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cardiac Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cardiac Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cardiac Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cardiac Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cardiac Biomarkers Sales (K Units) and Growth Rate (2012-2022)
Figure United States Cardiac Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cardiac Biomarkers Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Cardiac Biomarkers Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Cardiac Biomarkers Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cardiac Biomarkers Sales Share by Players/Suppliers
Figure 2017 United States Cardiac Biomarkers Sales Share by Players/Suppliers
Figure United States Cardiac Biomarkers Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cardiac Biomarkers Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cardiac Biomarkers Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cardiac Biomarkers Revenue Share by Players/Suppliers
Figure 2017 United States Cardiac Biomarkers Revenue Share by Players/Suppliers
Table United States Market Cardiac Biomarkers Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Cardiac Biomarkers Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Cardiac Biomarkers Market Share of Top 3 Players/Suppliers
Figure United States Cardiac Biomarkers Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cardiac Biomarkers Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cardiac Biomarkers Product Category
Table United States Cardiac Biomarkers Sales (K Units) by Region (2012-2017)
Table United States Cardiac Biomarkers Sales Share by Region (2012-2017)
Figure United States Cardiac Biomarkers Sales Share by Region (2012-2017)
Figure United States Cardiac Biomarkers Sales Market Share by Region in 2016
Table United States Cardiac Biomarkers Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cardiac Biomarkers Revenue Share by Region (2012-2017)
Figure United States Cardiac Biomarkers Revenue Market Share by Region (2012-2017)
Figure United States Cardiac Biomarkers Revenue Market Share by Region in 2016
Table United States Cardiac Biomarkers Price (USD/Unit) by Region (2012-2017)
Table United States Cardiac Biomarkers Sales (K Units) by Type (2012-2017)
Table United States Cardiac Biomarkers Sales Share by Type (2012-2017)
Figure United States Cardiac Biomarkers Sales Share by Type (2012-2017)
Figure United States Cardiac Biomarkers Sales Market Share by Type in 2016
Table United States Cardiac Biomarkers Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cardiac Biomarkers Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cardiac Biomarkers by Type (2012-2017)
Figure Revenue Market Share of Cardiac Biomarkers by Type in 2016
Table United States Cardiac Biomarkers Price (USD/Unit) by Types (2012-2017)
Figure United States Cardiac Biomarkers Sales Growth Rate by Type (2012-2017)
Table United States Cardiac Biomarkers Sales (K Units) by Application (2012-2017)
Table United States Cardiac Biomarkers Sales Market Share by Application (2012-2017)
Figure United States Cardiac Biomarkers Sales Market Share by Application (2012-2017)
Figure United States Cardiac Biomarkers Sales Market Share by Application in 2016
Table United States Cardiac Biomarkers Sales Growth Rate by Application (2012-2017)
Figure United States Cardiac Biomarkers Sales Growth Rate by Application (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Cardiac Biomarkers Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Cardiac Biomarkers Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Cardiac Biomarkers Revenue Market Share in United States (2012-2017)
Table Alere Basic Information List
Table Alere Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alere Cardiac Biomarkers Sales Growth Rate (2012-2017)
Figure Alere Cardiac Biomarkers Sales Market Share in United States (2012-2017)
Figure Alere Cardiac Biomarkers Revenue Market Share in United States (2012-2017)
Table Siemens Healthcare GmbH Basic Information List
Table Siemens Healthcare GmbH Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens Healthcare GmbH Cardiac Biomarkers Sales Growth Rate (2012-2017)
Figure Siemens Healthcare GmbH Cardiac Biomarkers Sales Market Share in United States (2012-2017)
Figure Siemens Healthcare GmbH Cardiac Biomarkers Revenue Market Share in United States (2012-2017)
Table Roche Diagnostics Corporation Basic Information List
Table Roche Diagnostics Corporation Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Diagnostics Corporation Cardiac Biomarkers Sales Growth Rate (2012-2017)
Figure Roche Diagnostics Corporation Cardiac Biomarkers Sales Market Share in United States (2012-2017)
Figure Roche Diagnostics Corporation Cardiac Biomarkers Revenue Market Share in United States (2012-2017)
Table Beckman Coulter, Inc. Basic Information List
Table Beckman Coulter, Inc. Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beckman Coulter, Inc. Cardiac Biomarkers Sales Growth Rate (2012-2017)
Figure Beckman Coulter, Inc. Cardiac Biomarkers Sales Market Share in United States (2012-2017)
Figure Beckman Coulter, Inc. Cardiac Biomarkers Revenue Market Share in United States (2012-2017)
Table BG Medicines Basic Information List
Table BG Medicines Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BG Medicines Cardiac Biomarkers Sales Growth Rate (2012-2017)
Figure BG Medicines Cardiac Biomarkers Sales Market Share in United States (2012-2017)
Figure BG Medicines Cardiac Biomarkers Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific, Inc. Basic Information List
Table Thermo Fisher Scientific, Inc. Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific, Inc. Cardiac Biomarkers Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific, Inc. Cardiac Biomarkers Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific, Inc. Cardiac Biomarkers Revenue Market Share in United States (2012-2017)
Table BioMerieux SA Basic Information List
Table BioMerieux SA Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioMerieux SA Cardiac Biomarkers Sales Growth Rate (2012-2017)
Figure BioMerieux SA Cardiac Biomarkers Sales Market Share in United States (2012-2017)
Figure BioMerieux SA Cardiac Biomarkers Revenue Market Share in United States (2012-2017)
Table Bio-Rad Laboratories Basic Information List
Table Bio-Rad Laboratories Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories Cardiac Biomarkers Sales Growth Rate (2012-2017)
Figure Bio-Rad Laboratories Cardiac Biomarkers Sales Market Share in United States (2012-2017)
Figure Bio-Rad Laboratories Cardiac Biomarkers Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cardiac Biomarkers
Figure Manufacturing Process Analysis of Cardiac Biomarkers
Figure Cardiac Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Cardiac Biomarkers Major Players/Suppliers in 2016
Table Major Buyers of Cardiac Biomarkers
Table Distributors/Traders List
Figure United States Cardiac Biomarkers Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Cardiac Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cardiac Biomarkers Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Cardiac Biomarkers Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cardiac Biomarkers Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cardiac Biomarkers Sales Volume (K Units) Forecast by Type in 2022
Table United States Cardiac Biomarkers Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cardiac Biomarkers Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cardiac Biomarkers Sales Volume (K Units) Forecast by Application in 2022
Table United States Cardiac Biomarkers Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Cardiac Biomarkers Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cardiac Biomarkers Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cardiac Biomarkers Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Cardiac Biomarkers Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports